Browse
Submit Data
Databases
API
Help

Dataset Information

10 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rac-4a,10b-cis,10b,5c-trans-5-(7-Methyl-2-oxo-2H-chromen-4-yl)-3,4,4a,5,6,10b-hexa-hydro-2H-pyrano[3,2-c]quinoline.

ABSTRACT: In the racemic title compound, C(22)H(21)NO(3), the nitro-gen-containing ring of the pyran-oquinoline moiety adopts a slightly distorted half-chair conformation and the oxygen-containing ring adopts a slightly distorted chair conformation. The benzene rings make a dihedral angle of 84.97?(8)°. In the crystal, weak C-H?O inter-actions link the mol-ecules into chains extending along the a-axis direction.

SUBMITTER: Kayalvizhi M

PROVIDER: S-EPMC3569807 | biostudies-other | 2013 Feb

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

rac-4a,10b-cis,10b,5c-trans-5-(7-Methyl-2-oxo-2H-chromen-4-yl)-3,4,4a,5,6,10b-hexa-hydro-2H-pyrano[3,2-c]quinoline.

Kayalvizhi M M Vasuki G G Samant Shriniwas D SD Sanap Kailas K KK

Acta crystallographica. Section E, Structure reports online 20130123 Pt 2

In the racemic title compound, C(22)H(21)NO(3), the nitro-gen-containing ring of the pyran-oquinoline moiety adopts a slightly distorted half-chair conformation and the oxygen-containing ring adopts a slightly distorted chair conformation. The benzene rings make a dihedral angle of 84.97 (8)°. In the crystal, weak C-H⋯O inter-actions link the mol-ecules into chains extending along the a-axis direction. ...[more]

PMID: 23424553

Similar Datasets

5-Phenyl-3,4,4a,5,6,12c-hexa-hydro-2H-benzo[f]pyrano[3,2-c]quinoline.

Project description:In the title compound, C(22)H(21)N, the pyridine ring adopts a distorted boat conformation, while the adjacent pyran ring adopts a chair conformation; the heterocyclic rings make a dihedral angle of 40.1 (2)° with each other.

| S-EPMC3006965 | biostudies-literature

10-Phenyl-6b,7,8,9,9a,10-hexa-hydro-6H-cyclo-penta-[4,5]pyrano[3,2-c]chromen-6,9-dione.

Project description:In the title compound, C(21)H(16)O(4), the dihedral angle between the phenyl ring and the 2H-chromene ring system is 59.8?(2)°. The crystal packing is stabilized by weak ?-? stacking inter-actions [centroid-centroid distances = 3.667?(2)?Å] and inter-molecular C-H?O hydrogen-bonding inter-actions.

| S-EPMC3099813 | biostudies-other

rac-(4aR,8aR)-2,3-Diphenyl-4a,5,6,7,8,8a-hexa-hydro-quinoxaline.

Project description:The structure of the title racemic compound, C(20)H(20)N(2), shows close similarity to that of the enanti-omerically pure (4aR,8aR)-2,3-diphenyl-4a,5,6,7,8,8a-hexa-hydro-quinoxaline [Wang & Ye (2008 ?). Acta Cryst. E64, o359-o359]. The similarity applies to the unit-cell parameters as well as to the packing of the constituent mol-ecules. Similar packing is conditioned by a lack of directed inter-molecular inter-actions such as hydrogen bonds in either structure.

| S-EPMC2961730 | biostudies-literature

6-Meth-oxy-2-phenyl-4,4a,6,7,8,8a-hexa-hydro-2H-pyrano[3,2-d][1,3]dioxine-7,8-diyl bis-(4-methyl-benzene-1-sulfonate).

Project description:In the title ?-D-glucopyran-oside derivative, C(28)H(30)O(10)S(2), each heterocyclic ring adopts a chair conformation. In the tri-substituted ring, the meth-oxy and one sulfonate group occupy axial positions, whereas the second sulfonate group occupies an axial position. The phenyl group on the other ring is in an equatorial position. In the crystal, supra-molecular chains propagating along [100] are formed through C-H?O and C-H?? inter-actions.

| S-EPMC3295524 | biostudies-literature

8-Methyl-4-phenyl-2,3,3a,4,5,9b-hexa-hydro-furo[3,2-c]quinoline.

Project description:The title compound, C(18)H(19)NO, was synthesized from the multi-component one-pot reaction between p-toluidine, benzaldehyde and 2,3-dihydro-furan in the presence of palladium dichloride. There are two mol-ecules in the asymmetric unit. The crystal packing is stabilized by classical inter-molecular N-H?O hydrogen bonds.

| S-EPMC2980039 | biostudies-literature

4-(2-Bromo-phen-yl)-2-phenyl-pyrano[3,2-c]chromen-5(4H)-one.

Project description:In the title compound, C24H15BrO3, the pyran-ochromenone ring is essentially planar, while the 2-bromo-phenyl group is almost perpendicular to it [85.58?(6)°]. In the crystal, inversion dimers linked by pairs of weak C-H?? bonds occur; there is also a short inter-atomic contact found between the Br and carbonyl O atoms [3.016?(1)?Å].

| S-EPMC3588827 | biostudies-other

1-(5-Hy-droxy-2,2,8,8-tetra-methyl-2H,8H-pyrano[2,3-f]chromen-6-yl)ethanone.

Project description:In the title compound, C(18)H(20)O(4),the pyran ring of the chromene unit adopts a half-chair conformation. An intra-molecular O-H?O hydrogen bond occurs. In the crystal, mol-ecules are linked along the b axis by C-H?O hydrogen bonds.

| S-EPMC3470397 | biostudies-literature

Synthesis and Biological Screening of Pyrano[3,2-c]quinoline Analogues as Anti-inflammatory and Anticancer Agents.

Project description:A series of pyrano[3,2-c]quinoline based structural analogues was synthesized using one-pot multicomponent condensation between 2,4-dihydroxy-1-methylquinoline, malononitrile, and diverse un(substituted) aromatic aldehydes. The synthesized compounds were evaluated for their anti-inflammatory and cytotoxicity activity. Initially, all the compounds were evaluated for the percent inhibition of cytokine release, and cytotoxicity activity and 50% inhibitory concentrations (IC50) were also determined. Based on the primary results, it was further studied for their ability to inhibit TNF-? production in the human peripheral blood mononuclear cells (hPBMC) assay. The screening results revealed that compound 4c, 4f, 4i, and 4j were found most active candidates of the series against both anti-inflammatory and anticancer activity. The structure-activity relationship is discussed and suggested that 3-substitution on the aryl ring at C4 position of the pyrano[3,2-c]quinolone structural motif seems to be an important position for both TNF-? and IL-6 inhibition and anticancer activity as well. However, structural diversity with electron withdrawing, electron donating, sterically hindered, and heteroaryl substitution sincerely affected both the inflammation and anticancer activities.

| S-EPMC5846041 | biostudies-literature

Crystal structure of 2-methyl-amino-3-nitro-4-p-tolyl-pyrano[3,2-c]chromen-5(4H)-one.

Project description:In the racemic title compound, C20H16N2O5, the pyran ring adopts a shallow envelope conformation, with the stereogenic C atom displaced from the other atoms by 0.273?(2)?Å. The dihedral angle between the fused-ring system and the pendant p-tolyl group is 87.62?(7)°. The mol-ecular conformation is consolidated by an intra-molecular N-H?O hydrogen bond, which generates an S(6) ring. In the crystal, mol-ecules are linked by C-H?O inter-actions, resulting in [010] chains.

| S-EPMC4350753 | biostudies-literature

rac-Dimethyl 2-(tert-butyl-amino)-5-oxo-4,5-dihydro-pyrano[3,2-c]chromene-3,4-dicarboxyl-ate.

Project description:The title compound, C(20)H(21)NO(7), is asymmetric with a chiral centre located in the pyran ring and crystallizes as a racemate. The mol-ecular framework is somewhat bent; the coumarin moiety and the pyran ring are inclined by 7.85?(5)°. The mol-ecular structure is characterized by an intra-molecular N-H?O hydrogen bond, which generates an S(6) ring motif, and the crystal packing is stabilized by inter-molecular C-H?O hydrogen bonds. The 3-carboxyl-ate O atom is involved in both of them, having a bifurcated character.

| S-EPMC3247363 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data